Biogen

Anonymous board for Biogen
Post thread


FiercePharma: Leqembi launch hamstrung by physicians' 'therapeutic nihilism'
Replies
3
Views
1K
anonymous
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start
Replies
2
Views
895
anonymous
It's the first drug shown to slow Alzheimer's. Why is it off to a slow start? | AP News
Replies
2
Views
899
anonymous
Too much of a risk for Alzheimers Drug
Replies
336
Views
48K
anonymous
DOJ, SEC Subpoenas Add to Biogen’s Compounding Problems | BioSpace
Replies
7
Views
3K
anonymous
Miami
Replies
1
Views
1K
anonymous
FAM Bonus/RSU %
Replies
5
Views
2K
anonymous
Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s | BioSpace
Replies
1
Views
982
anonymous
Fierce Pharma: Eisai's Leqembi launch tripped up on a host of challenges
Replies
6
Views
2K
anonymous
Biogen relying on success of Leqembi following discontinuation of Aduhelm
Replies
1
Views
1K
anonymous
Biogen CEO plots long-term turnaround after analysts brand company's recent results as 'weak'
Replies
17
Views
4K
anonymous
Neurologists Report Frustration with Efficacy and Logistical Issues Around Eisai/Biogen’s Leqembi
Replies
1
Views
1K
anonymous
https://wallmine.com/people/122433/rachid-izzar
Replies
0
Views
1K
anonymous
Biogen Misses Q4 Revenue Estimates on Aduhelm Costs, Lower MS Drug Sales | BioSpace
Replies
5
Views
2K
anonymous
Yet another Biogen fraud. Whistleblower
Replies
1
Views
2K
anonymous
Deb Making Her Mark
Replies
2
Views
3K
anonymous
Eisai delays Alzheimer’s patient goal deadline amid subpar sales for Leqembi – Endpoints News
Replies
1
Views
1K
anonymous
Did it begin or end as a whimper
Replies
2
Views
1K
anonymous
The Biogen Aduhelm mess could happen again - STAT
Replies
0
Views
901
anonymous
NBC: Biogen to stop selling controversial Alzheimer's drug Aduhelm
Replies
4
Views
1K
anonymous
Top Bottom
Back
Post thread